Ann: HeraMED Receives FDA 510(k) Clearance for HeraBEAT Device, page-496

Catylist can be announce any time.
for example USA deal, revenues and huge distribution deals.

up coming news, public:

- OB Nest, a service model that offers a customized approach to in-home monitoring, was developed in collaboration with Mayo Clinic Department of Obstetrics & Gynaecology, and the Centre for The Science of Health Care Delivery.
While the development of this platform is currently underway, soft launch is anticipated in 2020.

- Successfully passing the first stage of approvals process, HeraMED secured its place in the final list of the Israel Innovation Authority (IIA) for financial non-dilutive grant which would be utlilised to fund development and integration of its HeraCARE including R&D, production modification, regulatory approvals and establishing beta programs.
The grant is being issued as a collaboration between the Mayo Clinic and the Israeli government to boost collaborations between Mayo Clinic innovators and promising local
Subject to approval, HeraMED would receive approximately 50% of the project costs for a period of two years.  The decision is expected by Q1 2020 end.